AXIM BIOTECHNOLOGIES, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Axim Biotechnologies, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Axim Biotechnologies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $183K, a 32.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $183K -$87.4K -32.4% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $205K +$200K +4013% Mar 31, 2024 10-Q/A 2024-05-22
Q4 2023 $227K +$207K +1047% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 $249K +$214K +624% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $270K +$221K +454% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $4.98K -$57.9K -92.1% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $19.8K -$57.1K -74.3% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $34.4K -$56.3K -62.1% Sep 30, 2022 10-Q/A 2022-11-15
Q2 2022 $48.7K -$55.4K -53.2% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 $62.9K -$54.6K -46.5% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $76.9K -$53.9K -41.2% Dec 31, 2021 10-K 2023-04-17
Q3 2021 $90.6K -$53.1K -36.9% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $104K -$52.3K -33.4% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 $118K Mar 31, 2021 10-Q/A 2021-06-02
Q4 2020 $131K +$131K Dec 31, 2020 10-K/A 2022-04-19
Q3 2020 $144K Sep 30, 2020 10-Q/A 2020-11-27
Q2 2020 $156K Jun 30, 2020 10-Q/A 2020-08-18
Q4 2019 $0 Dec 31, 2019 10-K/A 2021-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.